Superfood of the future
Meat consumption has come under fire because it is harmful to the climate. At the same time, components of the hemp plant are increasingly being incorporated into products.
Receive up-to-date information about the company directly via push notification
What will our diet look like in the future? If worms, maggots and grasshoppers are really going to be a source of protein or algae are going to take the lead, the consumer will decide. Algae are undemanding, contain many minerals and there are about 150 edible species. Some algae contain up to 40 percent protein. Around 60 percent of insects are made up of protein. No wonder that billions of people already eat them regularly.
For comparison: Lean beef provides only 26 grams of protein per hundred grams. But also soy flakes (40 percent), parmesan (38 percent) or hemp seeds (36 percent) contain protein. Especially athletes consider hemp as a new superfood. In Europe, for example, low-THC plants are processed into flour, spreads or biscuits. CBD oil is also touted as an aid to weight loss in dietary supplements.
However, there are exciting companies that take care of nutrition and hemp products such as RavenQuest BioMed or EnWave.
RavenQuest BioMed - https://www.commodity-tv.net/c/search_adv/?v=299207 - has two state-of-the-art hemp production facilities in Markham and Edmonton, Canada. The inspectors of Health Canada (who granted the necessary sales license) certified that the production is extremely pure without pesticides and aflatoxins. Only a few Canadian producers are able to do this. Not only one of the cleanest cannabis production sites, but also a special cultivation technology should ensure further success.
EnWave - https://www.commodity-tv.net/c/search_adv/?v=299137 - with its dehydration technology is important for many producers in the food, pharmaceutical and hemp industries. Drying and preservation bring EnWave royalties. Numerous well-known companies already use the company's REV™ machines.
Current company information and press releases from RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc/) and EnWave (https://www.resource-capital.ch/en/companies/enwave-corp/).
In accordance with §34 WpHG I would like to point out that partners, authors and employees may hold shares in the respective companies and that there is therefore a potential conflict of interest. No guarantee for the translation into German. Only the English version of these messages is valid.
Disclaimer: The information provided does not constitute any form of recommendation or advice. The risks involved in securities trading are expressly pointed out. No liability can be accepted for damages arising from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. For the correctness of all contents however no guarantee is taken over. Despite the greatest care, I expressly reserve the right to make an error, particularly with regard to figures and prices. The information contained herein has been obtained from sources believed to be reliable, but does not claim to be accurate or complete. Due to judicial judgements the contents of linked external sides are to be answered for also (so among other things regional court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no express dissociation from these takes place. Despite careful content control, I do not assume any liability for the content of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also https://www.resource-capital.ch/en/disclaimer/